Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy
The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.
关键词:综合
原文链接:https://www.cnbc.com/2026/11/18/hims-hers-peptides-plus-treatments.html
本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/c4f24e9ec0f1e6d5。